LS
INSM icon

Livforsakringsbolaget Skandia’s Insmed INSM Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Hold
4,412
– – 0.01% 260
2026
Q1 		$470K Buy
4,412
+2,912
+194% +$448K 0.02% 226
2025
Q4 		$261K Buy
+1,500
New +$274K 0.01% 296

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Livforsakringsbolaget Skandia's INSM Position: Q2 2026 in Review

Livforsakringsbolaget Skandia held its Insmed (INSM) position steady in Q2 2026 at 4,412 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #260.

Livforsakringsbolaget Skandia first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $470K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Livforsakringsbolaget Skandia held 4,412 shares of Insmed worth $368K as of Q2 2026.
  • Livforsakringsbolaget Skandia left its Insmed share count unchanged in Q2 2026.
  • Insmed made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q2 2026, its #260 holding.
  • Livforsakringsbolaget Skandia first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Livforsakringsbolaget Skandia's Insmed position peaked at $470K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2026, filed 18 Aug 2026.